PATENT CLAIM ANALYSIS

Application Number: 16204166
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-07
Patent Classification: ["544", "242000"]

Abstract:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Claim (Index 17):
The method of  claim 12 , wherein before administering the therapeutically effective amount of the compound of Formula (I), the individual is known to be refractory to a compound selected from the group consisting of a HBV polymerase inhibitor, interferon, viral entry inhibitor, viral maturation inhibitor, distinct capsid assembly modulator, inducer of cellular viral RNA sensor, therapeutic vaccine, antiviral compounds of distinct or unknown mechanism, and combination thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 98.0
- Lexical Diversity: 1.73016
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15209150', '15088517', '15216124', '16194608', '15421777']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8511253412712627
- 35 USC 102 Novelty (BERT): 0.5439595774457098
- Combined Prediction Score: 0.8204087648887074
- Mean Citation Score: 392.076462
- Max Citation Score: 423.04852
- Similarity Product: 325.49769211343533

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test